DENALI THERAPEUTICS INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • November 27th, 2017 • Denali Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of , 2017 and is between Denali Therapeutics Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
Denali Therapeutics Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • November 27th, 2017 • Denali Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Denali Therapeutics Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of the Common Stock, par value $0.01 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
